Transcranial direct current stimulation to improve walking in stroke patients
Transcranial Direct Current Stimulation of the Dorsolateral Prefrontal Cortex Enhances Dual-task Performance in People With Stroke
NA · The Hong Kong Polytechnic University · NCT06818240
This study is testing if a brain stimulation technique can help stroke survivors walk better while doing two things at once.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 50 Years to 80 Years |
| Sex | All |
| Sponsor | The Hong Kong Polytechnic University (other) |
| Locations | 1 site (Hong Kong, China) |
| Trial ID | NCT06818240 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of transcranial direct current stimulation (tDCS) on dual-task walking performance in individuals who have experienced a chronic stroke. Participants will receive either active or sham tDCS targeting the left dorsolateral prefrontal cortex, followed by assessments of their walking speed and cognitive task performance. The study employs a cross-over design with two sessions spaced a week apart, measuring outcomes such as stride length and dual-task cost. The goal is to determine if tDCS can enhance mobility and cognitive function during dual-task activities.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 50 to 80 years who are at least six months post-first-ever stroke with unilateral motor deficits and can walk independently.
Not a fit: Patients with unstable medical conditions, significant comorbidities affecting gait, or contraindications to tDCS may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve the daily functioning and quality of life for stroke survivors by enhancing their ability to walk while engaging in cognitive tasks.
How similar studies have performed: While the use of tDCS in stroke rehabilitation is gaining interest, this specific application targeting dual-task performance is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * age between 50 and 80 years * at least 6 months post-first-ever stroke with unilateral motor deficits * ability to walk independently for at least 10 m without the use of walking aids * a score of 24 or higher on the Mini-Mental State Examination (MMSE) Exclusion Criteria: * unstable medical conditions, such as heart failure, uncontrolled hypertension, or cancer * presence of other comorbidities that could interfere with gait * history of contraindications to tDCS, such as epilepsy or metal implants * history of head injury, head surgery, or lower limb orthopedic issues
Where this trial is running
Hong Kong, China
- The Hong Kong Polytechnic University — Hong Kong, China, Hong Kong (RECRUITING)
Study contacts
- Principal investigator: Shamay SM NG, PhD — The Hong Kong Polytechnic University
- Study coordinator: Shamay SM NG, PhD
- Email: shamay.ng@polyu.edu.hk
- Phone: +85227664889
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Chronic Stroke, transcranial direct current stimulation, stroke, dual task